Dabomb Protein (6578) — Cash Flow Reinvestment Rate
Dabomb Protein (6578) has a Cash Flow Reinvestment Rate of 3.69x as of March 2025, reinvesting NT$29.94 Million (capex NT$20.59 Million plus investments NT$9.35 Million) from operating cash flow of NT$8.12 Million. See 6578 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dabomb Protein Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Dabomb Protein across 10 annual periods. For the full cash flow conversion analysis, see 6578 cash flow conversion.
Annual Cash Flow Reinvestment Rate for Dabomb Protein (2015–2025)
Year-by-year capital reinvestment analysis for Dabomb Protein. See 6578 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.64x | NT$60.61 Million | NT$16.65 Million | NT$37.69 Million | ▲ +435.7% |
| 2024 | 0.68x | NT$32.32 Million | NT$47.55 Million | NT$30.32 Million | ▼ -91.3% |
| 2023 | 7.80x | NT$50.77 Million | NT$6.51 Million | NT$18.87 Million | ▲ +189.9% |
| 2022 | 2.69x | NT$53.05 Million | NT$19.71 Million | NT$20.16 Million | ▼ -43.4% |
| 2020 | 4.76x | NT$63.80 Million | NT$13.41 Million | NT$18.31 Million | ▲ +69.4% |
| 2019 | 2.81x | NT$93.39 Million | NT$33.26 Million | NT$91.81 Million | ▼ -62.4% |
| 2018 | 7.46x | NT$164.65 Million | NT$22.07 Million | NT$163.06 Million | ▲ +94.3% |
| 2017 | 3.84x | NT$168.40 Million | NT$43.87 Million | NT$166.46 Million | ▲ +27.2% |
| 2016 | 3.02x | NT$179.88 Million | NT$59.58 Million | NT$92.71 Million | ▲ +7354.3% |
| 2015 | 0.04x | NT$5.66 Million | NT$139.78 Million | NT$5.33 Million | — |